A, Warszawa N Clinical Trials

A listing of A, Warszawa N clinical trials actively recruiting patients volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 152 clinical trials
Featured trial
A Phase 2, Multi-center, Randomized, Double-Blind, Parallel-Group, Dose-Finding Study to Assess the Effect of Four Doses of MM-120 for the Treatment of Anxiety Symptoms

This is a Phase 2, multi-center, randomized, double-blind, parallel-group, dose-finding study to assess the effect of 4 doses of MM-120 (25, 50, 100 or 200 μg freebase-equivalent) for the

Accepts healthy volunteers
  • 0 views
  • 01 Feb, 2023
  • 19 locations
Featured trial
Ascend-Nash: A Phase 2b, Randomized, Multi-Center, Double-Blind, Placebo-Controlled Study To Evaluate The Efficacy And Safety Of Crv431 In Adult Subjects With Nonalcoholic Steatohepatitis And Advanced Liver Fibrosis

biopsy-proven nonalcoholic steatohepatitis (NASH) and stage 2 liver fibrosis (F2) / stage 3 liver fibrosis (F3).Exploratory:To validate the use of a composite NASH multi-omics AI-POWR™ biomarker

  • 0 views
  • 29 Sep, 2022
  • 1 location
Featured trial
Summit Max: A Prospective, Randomized, Controlled, Interventional Clinical Trial to Evaluate the Safety and Effectiveness of the Route 92 Medical MonoPoint® Reperfusion System for Aspiration Thrombectomy in Acute Ischemic Stroke Patients

The SUMMIT MAX study is a prospective, randomized, controlled, interventional clinical trial to evaluate the safety and effectiveness of the Route 92 Medical MonoPoint® Reperfusion System for

  • 0 views
  • 29 Nov, 2022
  • 1 location
Featured trial
EF-36/Keynote: A pilot, single arm, open-label study of Tumor Treating Fields (TTFields, 150 kHz) concomitant with pembrolizumab for first line treatment of advanced or metastatic intrathoracic non-small cell lung cancer

This is a multicenter, single arm, open-label study of Tumor Treating Fields (TTFields) at 150 kHz to the thorax using the NovoTTF-200T System concomitant with IV pembrolizumab (also known as MK

  • 0 views
  • 29 Nov, 2022
  • 1 location
Featured trial
  • 0 views
  • 09 Dec, 2022
  • 1 location
Featured trial
A Double-Blinded, Placebo-controlled, Multi-center Randomized, Phase 3 Study to Evaluate the Efficacy and Safety of ORMD-0801 in Subjects with Type 2 Diabetes Mellitus with Inadequate Glycemic Control on Diet Control Alone or on Diet Control and Metformin Monotherapy

Do you have Type II Diabetes? Do you often feel like your glucose levels are all over the place? Would you want to be involved in a clinical study to improve the treatment options for Type II

  • 0 views
  • 13 Sep, 2022
  • 1 location
Featured trial
A Multicenter, Randomized, Double-Blind, Placebo-Controlled 12-Week Study To Evaluate The Safety And Efficacy Of Oral Difelikefalin In Advanced Chronic Kidney Disease Subjects With Moderate-To-Severe Pruritus And Not On Dialysis With An Up To 52-Week Long-Term Extension

the results of a planned interim assessment conducted when approximately 50% of the planned 400 subjects have been randomized and have either completed the 12-week Treatment Period 1 or have

  • 0 views
  • 29 Sep, 2022
  • 1 location
Featured trial
A 52-week study comparing the efficacy and safety of once weekly IcoSema and once weekly insulin Icodec, both treatment arms with or without oral anti-diabetic drugs, in participants with type 2 diabetes inadequately controlled with daily basal insulin. COMBINE 1

Objective: To confirm superiority of once weekly IcoSema compared with once weekly insulin Icodec, both treatment arms with or without OADs, in terms of glycaemic control measured by change in HbA1c from baseline after 52 weeks in participants with T2D inadequately controlled with daily basal insulin.

  • 0 views
  • 29 Sep, 2022
  • 1 location
Featured trial
  • 0 views
  • 11 Nov, 2022
  • 1 location
Featured trial
  • 0 views
  • 30 Dec, 2022
  • 1 location